Todd Brinton, M.D.

Fellowship Director
Clinical Associate Professor of Medicine (Cardiology)
Lecturer in Bioengineering
Stanford University
Stanford, CA

Dr. Brinton is a Clinical Associate Professor of Medicine (Cardiology) and Lecturer in Bioengineering at Stanford University. He is an attending interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He is also the fellowship director for the program in biodesign innovation and co-director of the graduate class in biodesign innovation.

His responsibilities include coaching and mentorship of the innovation fellows and direction of the graduate course in biodesign innovation. Dr. Brinton’s academic research focuses on the development of novel medical technologies and pre-clinical evaluation. His specific focus has been the evaluation of techniques for cardiac stem cell transplantation. He is also active in clinical trials of interventional-based therapies for chronic ischemia heart disease and heart failure.

Dr. Brinton completed his medicine, cardiology, and interventional training at Stanford University. He holds an M.D from the Chicago Medical School and B.S in bioengineering from the University of California, San Diego. He is co-founder of BioParadox, Inc., a venture-backed medical device company and serves on the board of directors of Infogard laboratories, a security company focused on medical records and wireless medical devices. He also serves on the advisory board of a number of early-stage medical device companies where he focuses on clinical development and strategy. Prior to medical school he was the Clinical Research Director for Pulse Metric, Inc., a medical device start-up company.